Table of Contents

2019-2024 Global Biodefense Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Biodefense Consumption 2014-2024
  • 2.1.2 Biodefense Consumption CAGR by Region
• 2.2 Biodefense Segment by Type
  • 2.2.1 Anthrax
  • 2.2.2 Smallpox
  • 2.2.3 Botulism
  • 2.2.4 Radiation/Nuclear
  • 2.2.5 Others
• 2.3 Biodefense Consumption by Type
  • 2.3.1 Global Biodefense Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Biodefense Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Biodefense Sale Price by Type (2014-2019)
• 2.4 Biodefense Segment by Application
  • 2.4.1 US Military Market
  • 2.4.2 US Civilian Market
  • 2.4.3 Non - US Market
• 2.5 Biodefense Consumption by Application
  • 2.5.1 Global Biodefense Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Biodefense Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Biodefense Sale Price by Application (2014-2019)

3 Global Biodefense by Players

• 3.1 Global Biodefense Sales Market Share by Players
  • 3.1.1 Global Biodefense Sales by Players (2017-2019)
  • 3.1.2 Global Biodefense Sales Market Share by Players (2017-2019)
• 3.2 Global Biodefense Revenue Market Share by Players
  • 3.2.1 Global Biodefense Revenue by Players (2017-2019)
  • 3.2.2 Global Biodefense Revenue Market Share by Players (2017-2019)
• 3.3 Global Biodefense Sale Price by Players
• 3.4 Global Biodefense Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Biodefense Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Biodefense Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Biodefense by Regions

• 4.1 Biodefense by Regions
  • 4.1.1 Global Biodefense Consumption by Regions
  • 4.1.2 Global Biodefense Value by Regions
• 4.2 Americas Biodefense Consumption Growth
• 4.3 APAC Biodefense Consumption Growth
• 4.4 Europe Biodefense Consumption Growth
• 4.5 Middle East & Africa Biodefense Consumption Growth

5 Americas

• 5.1 Americas Biodefense Consumption by Countries
  • 5.1.1 Americas Biodefense Consumption by Countries (2014-2019)
  • 5.1.2 Americas Biodefense Value by Countries (2014-2019)
• 5.2 Americas Biodefense Consumption by Type
• 5.3 Americas Biodefense Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Biodefense Consumption by Countries
  • 6.1.1 APAC Biodefense Consumption by Countries (2014-2019)
  • 6.1.2 APAC Biodefense Value by Countries (2014-2019)
• 6.2 APAC Biodefense Consumption by Type
• 6.3 APAC Biodefense Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Biodefense by Countries
  • 7.1.1 Europe Biodefense Consumption by Countries (2014-2019)
  • 7.1.2 Europe Biodefense Value by Countries (2014-2019)
• 7.2 Europe Biodefense Consumption by Type
• 7.3 Europe Biodefense Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Biodefense by Countries
  • 8.1.1 Middle East & Africa Biodefense Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Biodefense Value by Countries (2014-2019)
• 8.2 Middle East & Africa Biodefense Consumption by Type
• 8.3 Middle East & Africa Biodefense Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Biodefense Distributors
• 10.3 Biodefense Customer

11 Global Biodefense Market Forecast

• 11.1 Global Biodefense Consumption Forecast (2019-2024)
• 11.2 Global Biodefense Forecast by Regions
  • 11.2.1 Global Biodefense Forecast by Regions (2019-2024)
  • 11.2.2 Global Biodefense Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Biodefense Forecast by Type
• 11.8 Global Biodefense Forecast by Application

12 Key Players Analysis

• 12.1 Emergent Biosolutions
  • 12.1.1 Company Details
  • 12.1.2 Biodefense Product Offered
  • 12.1.3 Emergent Biosolutions Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Emergent Biosolutions News
• 12.2 Hytest
  • 12.2.1 Company Details
  • 12.2.2 Biodefense Product Offered
  • 12.2.3 Hytest Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Hytest News
• 12.3 GSK
  • 12.3.1 Company Details
  • 12.3.2 Biodefense Product Offered
  • 12.3.3 GSK Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 GSK News
• 12.4 Sanofi
  • 12.4.1 Company Details
  • 12.4.2 Biodefense Product Offered
  • 12.4.3 Sanofi Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Sanofi News
• 12.5 PharmAthene
  • 12.5.1 Company Details
  • 12.5.2 Biodefense Product Offered
  • 12.5.3 PharmAthene Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 PharmAthene News
• 12.6 Bavarian Nordic
  • 12.6.1 Company Details
  • 12.6.2 Biodefense Product Offered
  • 12.6.3 Bavarian Nordic Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Bavarian Nordic News
• 12.7 SIGA Technologies
  • 12.7.1 Company Details
  • 12.7.2 Biodefense Product Offered
  • 12.7.3 SIGA Technologies Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 SIGA Technologies News
• 12.8 Arbutus Biopharma
  • 12.8.1 Company Details
  • 12.8.2 Biodefense Product Offered
  • 12.8.3 Arbutus Biopharma Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Arbutus Biopharma News
• 12.9 DynPort Vaccine
  • 12.9.1 Company Details
  • 12.9.2 Biodefense Product Offered
  • 12.9.3 DynPort Vaccine Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 DynPort Vaccine News
• 12.10 Xoma Corporation
  • 12.10.1 Company Details
  • 12.10.2 Biodefense Product Offered
  • 12.10.3 Xoma Corporation Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Xoma Corporation News
• 12.11 Ichor Medical Systems
• 12.12 Aeolus Pharmaceuticals
• 12.13 Achaogen
• 12.14 Elusys Therapeutics
• 12.15 Dynavax Technologies
• 12.16 Cleveland BioLabs
• 12.17 Soligenix
• 12.18 Alnylam Pharmaceuticals

13 Research Findings and Conclusion

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.

According to this study, over the next five years the Biodefense market will register a 8.5% CAGR in terms of revenue, the global market size will reach US$ 1390 million by 2024, from US$ 850 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biodefense business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biodefense market by product type, application, key manufacturers and key regions and countries.

This study considers the Biodefense value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
US Military Market
US Civilian Market
Non - US Market

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Biodefense consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Biodefense market by identifying its various subsegments.
Focuses on the key global Biodefense manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biodefense with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biodefense submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.